Mesoblast

Ultime notizie

Titoli nella lingua originale della fonte.

• Mesoblast Limited (ASX:MSB) Builds Ryoncil Revenue Base as FY26 Loss Narrows (si apre in una nuova scheda)

  Kalkine · 1 ott 2026

• State Street Group Cuts Mesoblast Stake Below Substantial Holder Threshold (si apre in una nuova scheda)

  TipRanks · 1 ott 2026

• Mesoblast Subject to State Street Substantial Holder Cessation Notice (si apre in una nuova scheda)

  Kalkine · 1 ott 2026

• Why Are Mesoblast (ASX:MSB) Shares Slipping Despite FDA Approval? (si apre in una nuova scheda)

  Kalkine Media · 1 ott 2026

• Mesoblast Limited Subject to New Substantial Holder Notice from State Street Corporation (si apre in una nuova scheda)

  Kalkine · 30 set 2026

• Has Mesoblast (ASX:MSB) Cleared a Key FDA Manufacturing Hurdle for Ryoncil? (si apre in una nuova scheda)

  Kalkine Media · 30 set 2026

• Mesoblast Limited Sponsored ADR Statistics – HAN:LWB1 (si apre in una nuova scheda)

  TradingView · 29 set 2026

• ETFs Investing in Mesoblast Limited Sponsored ADR Stocks (si apre in una nuova scheda)

  TradingView · 29 set 2026

• What Sets Pro Medicus, Mesoblast and Harvey Norman Apart? (si apre in una nuova scheda)

  Kalkine Media · 29 set 2026

• Has Mesoblast (ASX:MSB) cleared a key FDA manufacturing hurdle? (si apre in una nuova scheda)

  Kalkine Media · 28 set 2026

• Could Mesoblast shares rise over 100% in 12 months? (si apre in una nuova scheda)

  The Motley Fool Australia · 27 set 2026

• MEOBF Form 4 Filings - MESOBLAST LTD SEC Form 4 (si apre in una nuova scheda)

  Stock Titan · 27 set 2026

• Mesoblast (ASX:MSB) Secures FDA Approval for New Ryoncil Potency Assay (si apre in una nuova scheda)

  Kalkine · 26 set 2026

• Mesoblast (ASX:MSB) Stock Forecast & Analyst Predictions (si apre in una nuova scheda)

  Simply Wall Street · 25 set 2026

• Mesoblast (NASDAQ: MESO) Secures FDA Approval for TIBA Potency Assay in Ryoncil Production (si apre in una nuova scheda)

  Kalkine Media · 24 set 2026

• Mesoblast wins FDA nod for new potency assay for Ryoncil (si apre in una nuova scheda)

  Seeking Alpha · 24 set 2026

• Cantor Fitzgerald reiterates Mesoblast stock rating on adult trial focus (si apre in una nuova scheda)

  Investing.com · 24 set 2026

• Mesoblast receives FDA approval for new potency assay for Ryoncil (si apre in una nuova scheda)

  Investing.com · 24 set 2026

• Mesoblast (ASX:MSB): The Developments Investors Are Watching After FDA Approval for Ryoncil Potency Assay (si apre in una nuova scheda)

  Kalkine · 24 set 2026

• Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product (si apre in una nuova scheda)

  The Manila Times · 24 set 2026

• Every new batch of Mesoblast (NASDAQ: MESO)'s cell therapy will face another check after FDA approval. (si apre in una nuova scheda)

  Stock Titan · 24 set 2026

• Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil (si apre in una nuova scheda)

  TradingView · 24 set 2026

• Mesoblast wins FDA nod for new Ryoncil potency test (si apre in una nuova scheda)

  The Motley Fool Australia · 24 set 2026

• Mesoblast Receives FDA Approval for New RYONCIL Potency Assay (si apre in una nuova scheda)

  Kalkine · 24 set 2026

• ASX Healthcare Stocks to Watch in September 2026: Sigma Healthcare (ASX:SIG), Neuren Pharmaceuticals (ASX:NEU) and Mesoblast (ASX:MSB) (si apre in una nuova scheda)

  Kalkine · 14 set 2026

• Sigma Healthcare, Neuren and Mesoblast: Financial Performance Across ASX Healthcare (si apre in una nuova scheda)

  Kalkine · 14 set 2026

• Mesoblast (ASX: MSB) — Clinical Milestones and Commercial Ambitions: Why This Biotech Is in Focus (si apre in una nuova scheda)

  Kalkine · 7 set 2026

• Mesoblast (ASX:MSB): Ryoncil Revenue and Pipeline Expansion Redefine the Commercial Story (si apre in una nuova scheda)

  Kalkine · 7 set 2026

• Mesoblast (ASX:MSB): What Could Drive Its Next Move? (si apre in una nuova scheda)

  Kalkine Media · 4 set 2026

• Mesoblast (ASX:MSB) Holds Steady — Is Ryoncil's US Launch Enough to Watch This Biotech? (si apre in una nuova scheda)

  Kalkine · 4 set 2026